BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 32460821)

  • 1. Modeling the natural history of ductal carcinoma in situ based on population data.
    Chootipongchaivat S; van Ravesteyn NT; Li X; Huang H; Weedon-Fekjær H; Ryser MD; Weaver DL; Burnside ES; Heckman-Stoddard BM; de Koning HJ; Lee SJ
    Breast Cancer Res; 2020 May; 22(1):53. PubMed ID: 32460821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the natural progression of non-invasive ductal carcinoma in situ breast cancer lesions using screening data.
    Weedon-Fekjær H; Li X; Lee S
    J Med Screen; 2021 Sep; 28(3):302-310. PubMed ID: 32854582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches.
    van Ravesteyn NT; van den Broek JJ; Li X; Weedon-Fekjær H; Schechter CB; Alagoz O; Huang X; Weaver DL; Burnside ES; Punglia RS; de Koning HJ; Lee SJ
    Med Decis Making; 2018 Apr; 38(1_suppl):126S-139S. PubMed ID: 29554463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing the impact of 25 years of DCIS treatment.
    Ozanne EM; Shieh Y; Barnes J; Bouzan C; Hwang ES; Esserman LJ
    Breast Cancer Res Treat; 2011 Aug; 129(1):165-73. PubMed ID: 21390494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
    Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.
    Román M; Rué M; Sala M; Ascunce N; Baré M; Baroja A; De la Vega M; Galcerán J; Natal C; Salas D; Sánchez-Jacob M; Zubizarreta R; Castells X;
    PLoS One; 2013; 8(12):e83121. PubMed ID: 24376649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Dana-Farber CISNET Model for Breast Cancer Screening Strategies: An Update.
    Lee SJ; Li X; Huang H; Zelen M
    Med Decis Making; 2018 Apr; 38(1_suppl):44S-53S. PubMed ID: 29554465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
    van Luijt PA; Heijnsdijk EA; Fracheboud J; Overbeek LI; Broeders MJ; Wesseling J; den Heeten GJ; de Koning HJ
    Breast Cancer Res; 2016 May; 18(1):47. PubMed ID: 27160733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Ductal Carcinoma
    Ryser MD; Hendrix LH; Worni M; Liu Y; Hyslop T; Hwang ES
    Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1316-1323. PubMed ID: 31186262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiologic risk factors for in situ and invasive ductal breast cancer among regularly screened postmenopausal women by grade in the Cancer Prevention Study-II Nutrition Cohort.
    Puvanesarajah S; Gapstur SM; Gansler T; Sherman ME; Patel AV; Gaudet MM
    Cancer Causes Control; 2020 Jan; 31(1):95-103. PubMed ID: 31802322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
    Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
    Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women's characteristics: is it the same?
    Théberge I; Vandal N; Guertin MH; Perron L
    Breast Cancer Res Treat; 2019 Apr; 174(2):525-535. PubMed ID: 30564969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
    Groen EJ; Elshof LE; Visser LL; Rutgers EJT; Winter-Warnars HAO; Lips EH; Wesseling J
    Breast; 2017 Feb; 31():274-283. PubMed ID: 27671693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium.
    Allison KH; Abraham LA; Weaver DL; Tosteson AN; Nelson HD; Onega T; Geller BM; Kerlikowske K; Carney PA; Ichikawa LE; Buist DS; Elmore JG
    Cancer; 2015 May; 121(9):1369-78. PubMed ID: 25603785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural history of ductal carcinoma in situ (DCIS) in simulation models: A systematic review.
    Poelhekken K; Lin Y; Greuter MJW; van der Vegt B; Dorrius M; de Bock GH
    Breast; 2023 Oct; 71():74-81. PubMed ID: 37541171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
    Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
    Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
    Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
    Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
    Schultz S; Bartsch H; Sotlar K; Petat-Dutter K; Bonin M; Kahlert S; Harbeck N; Vogel U; Seeger H; Fehm T; Neubauer HJ
    BMC Med Genomics; 2018 Sep; 11(1):80. PubMed ID: 30236106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term psychosocial consequences of screen-detected ductal carcinoma in situ and invasive breast cancer.
    Gram EG; Manso TFR; Heleno B; Siersma V; Á Rogvi J; Brodersen JB
    Breast; 2023 Aug; 70():41-48. PubMed ID: 37307773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.